Selected research
Industry Growth & Trends
Global Human Single-Cell Multi-Omics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Human Single-Cell Multi-Omics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Human Single-Cell Multi-Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Human Single-Cell Multi-Omics market include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Human Single-Cell Multi-Omics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Human Single-Cell Multi-Omics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Single-Cell Multi-Omics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Single-Cell Multi-Omics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Human Single-Cell Multi-Omics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Human Single-Cell Multi-Omics Market by Company
10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio
Human Single-Cell Multi-Omics Segment by Type
Single-Cell Proteomics
Single-Cell Genomics
Single-Cell Transcriptomics
Human Single-Cell Multi-Omics Segment by Application
Synthetic Biology
Clinical Research
Translational Research
Human Single-Cell Multi-Omics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Single-Cell Multi-Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Single-Cell Multi-Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Single-Cell Multi-Omics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Human Single-Cell Multi-Omics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Cell Proteomics
- Single-Cell Genomics
- Single-Cell Transcriptomics
Applications
- Synthetic Biology
- Clinical Research
- Translational Research
Companies covered
- 10x Genomics
- 1CellBio
- BGI Genomics
- Bio-Rad Laboratories
- Celsee
- Fluidigm Corporation
- Fluxion Biosciences
- MissionBio
- NanoString Technologies
- Takara Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Human Single-Cell Multi-Omics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Human Single-Cell Multi-Omics Market Size by Region (2021-2032)
- 1.4.1 Global Human Single-Cell Multi-Omics Market Size by Region (2021-2026)
- 1.4.2 Global Human Single-Cell Multi-Omics Market Size by Region (2027-2032)
- 1.5 Key Regions Human Single-Cell Multi-Omics Market Size (2021-2032)
- 1.5.1 North America Human Single-Cell Multi-Omics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Human Single-Cell Multi-Omics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Human Single-Cell Multi-Omics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Human Single-Cell Multi-Omics Market Size Growth Rate (2021-2032)
2 Human Single-Cell Multi-Omics Market by Type
- 2.1 Type Introduction
- 2.1.1 Single-Cell Proteomics
- 2.1.2 Single-Cell Genomics
- 2.1.3 Single-Cell Transcriptomics
- 2.2 Global Human Single-Cell Multi-Omics Market Size by Type
- 2.2.1 Global Human Single-Cell Multi-Omics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Human Single-Cell Multi-Omics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Human Single-Cell Multi-Omics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Human Single-Cell Multi-Omics Market Size by Regions
- 2.3.1 North America Human Single-Cell Multi-Omics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Human Single-Cell Multi-Omics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Human Single-Cell Multi-Omics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Human Single-Cell Multi-Omics Market Size Breakdown by Type (2021-2026)
3 Human Single-Cell Multi-Omics Market by Application
- 3.1 Type Introduction
- 3.1.1 Synthetic Biology
- 3.1.2 Clinical Research
- 3.1.3 Translational Research
- 3.2 Global Human Single-Cell Multi-Omics Market Size by Application
- 3.2.1 Global Human Single-Cell Multi-Omics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Human Single-Cell Multi-Omics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Human Single-Cell Multi-Omics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Human Single-Cell Multi-Omics Market Size by Regions
- 3.3.1 North America Human Single-Cell Multi-Omics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Human Single-Cell Multi-Omics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Human Single-Cell Multi-Omics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Human Single-Cell Multi-Omics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Human Single-Cell Multi-Omics Industry Trends
- 4.2 Human Single-Cell Multi-Omics Industry Drivers
- 4.3 Human Single-Cell Multi-Omics Industry Opportunities and Challenges
- 4.4 Human Single-Cell Multi-Omics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Human Single-Cell Multi-Omics Revenue (2021-2026)
- 5.2 Global Human Single-Cell Multi-Omics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Human Single-Cell Multi-Omics Key Company Headquarters & Area Served
- 5.4 Global Human Single-Cell Multi-Omics Company, Product Type & Application
- 5.5 Global Human Single-Cell Multi-Omics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Human Single-Cell Multi-Omics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Human Single-Cell Multi-Omics Players Market Share by Revenue in 2025
- 5.6.3 2025 Human Single-Cell Multi-Omics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 10x Genomics
- 6.1.1 10x Genomics Company Information
- 6.1.2 10x Genomics Business Overview
- 6.1.3 10x Genomics Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 10x Genomics Human Single-Cell Multi-Omics Product Portfolio
- 6.1.5 10x Genomics Recent Developments
- 6.2 1CellBio
- 6.2.1 1CellBio Company Information
- 6.2.2 1CellBio Business Overview
- 6.2.3 1CellBio Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 1CellBio Human Single-Cell Multi-Omics Product Portfolio
- 6.2.5 1CellBio Recent Developments
- 6.3 BGI Genomics
- 6.3.1 BGI Genomics Company Information
- 6.3.2 BGI Genomics Business Overview
- 6.3.3 BGI Genomics Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BGI Genomics Human Single-Cell Multi-Omics Product Portfolio
- 6.3.5 BGI Genomics Recent Developments
- 6.4 Bio-Rad Laboratories
- 6.4.1 Bio-Rad Laboratories Company Information
- 6.4.2 Bio-Rad Laboratories Business Overview
- 6.4.3 Bio-Rad Laboratories Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio
- 6.4.5 Bio-Rad Laboratories Recent Developments
- 6.5 Celsee
- 6.5.1 Celsee Company Information
- 6.5.2 Celsee Business Overview
- 6.5.3 Celsee Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Celsee Human Single-Cell Multi-Omics Product Portfolio
- 6.5.5 Celsee Recent Developments
- 6.6 Fluidigm Corporation
- 6.6.1 Fluidigm Corporation Company Information
- 6.6.2 Fluidigm Corporation Business Overview
- 6.6.3 Fluidigm Corporation Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio
- 6.6.5 Fluidigm Corporation Recent Developments
- 6.7 Fluxion Biosciences
- 6.7.1 Fluxion Biosciences Company Information
- 6.7.2 Fluxion Biosciences Business Overview
- 6.7.3 Fluxion Biosciences Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio
- 6.7.5 Fluxion Biosciences Recent Developments
- 6.8 MissionBio
- 6.8.1 MissionBio Company Information
- 6.8.2 MissionBio Business Overview
- 6.8.3 MissionBio Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 MissionBio Human Single-Cell Multi-Omics Product Portfolio
- 6.8.5 MissionBio Recent Developments
- 6.9 NanoString Technologies
- 6.9.1 NanoString Technologies Company Information
- 6.9.2 NanoString Technologies Business Overview
- 6.9.3 NanoString Technologies Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio
- 6.9.5 NanoString Technologies Recent Developments
- 6.10 Takara Bio
- 6.10.1 Takara Bio Company Information
- 6.10.2 Takara Bio Business Overview
- 6.10.3 Takara Bio Human Single-Cell Multi-Omics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Takara Bio Human Single-Cell Multi-Omics Product Portfolio
- 6.10.5 Takara Bio Recent Developments
7 North America
- 7.1 North America Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 7.3 North America Human Single-Cell Multi-Omics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 8.3 Europe Human Single-Cell Multi-Omics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 10.3 South America Human Single-Cell Multi-Omics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Human Single-Cell Multi-Omics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Human Single-Cell Multi-Omics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst